Nexalin Technology, Inc. (NXL)
About Nexalin Technology, Inc.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $301.6K
- Net income
- -$8.2M
- Total assets
- $4.6M
- Market cap
- $10.6M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $10.6M
- Dividend yield
- 67.2%
- Shares outstanding
- 5.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 16, 2022
Nexalin Technology, Inc. (NXL) Stock Price
- Reported a net loss of $8.2M in FY2025.
- Trading 97% below its 52-week high.
- Pays a dividend yielding about 67.2% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Nexalin Technology, Inc..
Write a review
News about Nexalin Technology, Inc.
News & sentiment via Polygon.io
Nexalin Technology, Inc.: frequently asked questions
Is Nexalin Technology, Inc. an American company?
Nexalin Technology, Inc. is a US-based company headquartered in Houston, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Nexalin Technology, Inc. headquartered?
Nexalin Technology, Inc. is headquartered in Houston, Texas, United States.
Is Nexalin Technology, Inc. publicly traded?
Yes — Nexalin Technology, Inc. is a publicly traded company. Its stock trades under the ticker symbol NXL on the NASDAQ.
What does Nexalin Technology, Inc. do?
Nexalin Technology, Inc. is an American Medical Devices company in the Health & Beauty sector.
